Higher burden of breast cancer in Tamil Nadu, Telangana, Karnataka, Delhi: ICMR study
According to the projections, the burden of female breast cancer in India in 2025 is expected to be 5.6 million
Read moreAccording to the projections, the burden of female breast cancer in India in 2025 is expected to be 5.6 million
Read moreThe trials are carried out by Bharat Biotech in close collaboration with Biofabri. Trials to evaluate the safety and immunogenicity
Read moreLondon: The U.S. Food and Drug Administration said on Friday it had granted traditional approval for AbbVie’s “guided missile” cancer
Read moreE lon Musk’s brain-chip startup Neuralink livestreamed on Wednesday its first patient implanted with a chip playing online chess. Noland
Read moreNew Delhi: Cardiologists are advocating for additional research on the drug lecanemab that can add to the limited safety data,
Read more<img class="unveil" loading="eager" src="https://health.economictimes.indiatimes.com/Themes/Release/images/responsive/ethealthworld-default.jpg" data-src="https://etimg.etb2bimg.com/photo/108607755.cms" captionrendered="1" alt=" REUTERS/Amit Dave/File Photo “>REUTERS/Amit Dave/File Photo NEW DELHI: Supreme Court on Tuesday issued
Read moreIndore: The export of pharmaceutical products from Madhya Pradesh has seen a significant increase in the ongoing fiscal year with
Read moreSapporo: A new study has discovered a potential therapy target for immune-related conditions such as multiple sclerosis and asthma. A
Read moreThe panel consists of three core members: secretary, department of pharmaceuticals; senior economic advisor, department of pharmaceuticals; and chairman of
Read moreLondon: The U.S. Food and Drug Administration on Thursday expanded the use of Bristol Myers Squibb‘s cell therapy, Breyanzi, for
Read more